4
Changes in Ownership
INSMED Inc Filed Acc 0001628280-24-000698
Chief Commercial Officer sold 21,238 shares at an average $29.20 ($620,089)
- Chief Commercial Officer acquired 20,071 shares (option exercise)
- Chief Commercial Officer acquired 12,873 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Wise John Drayton · Chief Commercial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +20,071 | $19.11 | $383,557 | 124,055 | D |
| 2024-01-03 | Sale : show line 2 in the form 10b5-1 | −20,071 | $29.19 | $585,872 | 103,984 | D |
| 2024-01-04 | Grant or award : show line 3 in the form 10b5-1 | +12,873 | 116,857 | D | ||
| 2024-01-05 | Sale : show line 4 in the form 10b5-1 | −1,167 | $29.32 | $34,216 | 115,690 | D |
| Open-market sales · 21,238 sh · avg $29.20 · $620,089 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2024-01-03 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) | −20,071 | $19.11 | 2024-02-10 | 20,071 | 0 | D |
| 2024-01-04 | Grant or award : show line 6 in the form 10b5-1 Stock Option (right to buy) | +63,560 | $29.13 | 2034-01-04 | 63,560 | 63,560 | D |
Loading xslF345X05/wk-form4_1704494003.xml…